Advances and Opportunities to Address Co-Infections: CMV Retinitis and Hepatitis C
4
Advances and Opportunities to Address Co-Infections: CMV Retinitis and Hepatitis C IAS 2013 Sunday 30 July
description
Advances and Opportunities to Address Co-Infections: CMV Retinitis and Hepatitis C. IAS 2013 Sunday 30 July. Why Co-Infections…?. Co-infections remain important despite the success of ART roll out Late presenters - CMV Important co-infection even in face of ART - HCV - PowerPoint PPT Presentation
Transcript of Advances and Opportunities to Address Co-Infections: CMV Retinitis and Hepatitis C
Advances and Opportunities to Address Co-Infections:
CMV Retinitis and Hepatitis CIAS 2013
Sunday 30 July
Why Co-Infections…?Co-infections remain important despite the success
of ART roll outLate presenters - CMV Important co-infection even in face of ART - HCV
Need for additional political will and fundingTesting and treatment often not supportedFew guidelinesRegional importance
Key opportunitiesCMV: Potential for decentralization of screening,
diagnosis and treatmentHCV: Potential for paradigm shifting pipeline regimens
Goals: CMV and HCVExamine burden Explore challenges in
diagnosis and treatment
Share MSF experienceHighlight critical and
timely opportunities to improve access to diagnosis, treatment and care
AgendaCMV Retinitis – the neglected co-infection
Khin Nyein Chan, Nathan Ford Peter Saranchuk Arax Bozadjian**Respondant: Dr. Rewari
Hepatitis C – Increasing recognition of importance Nicolas Durier Isabelle Andrieux-Meyer Manica Balasegaram**Respondant: Shiba Phurailatpam
